Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04506268 · ClinicalTrials.gov registry record · NA
COVID-19 SAFE Enrollment
A NA study of Covid19, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 412
- Enrollment target
- 1
- Study location
NCT04506268 is a NA study of Covid19 that has completed, run by University of Pennsylvania. The registered enrollment target is 412 participants, below the 2,698-participant average among 94 other Covid19 trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04506268, a NA study of Covid19, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 412 participants
- Enrollment target
- 1
- Study location
Study Summary
In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. The investigators will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing and test different outreach strategies (opt-in vs opt-out) to improve program enrollment.
Conditions Studied
Interventions
- BEHAVIORAL Opt-out Recruitment Email
- BEHAVIORAL Opt-in Recruitment Email
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04506268
The ClinicalTrials.gov registry entry for NCT04506268 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,698-participant average among 94 other Covid19 trials with a reported enrollment target (85% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 2 interventions - of which Opt-out Recruitment Email is the first listed.
NCT04506268 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04506268 about?
NCT04506268 is a clinical study titled "COVID-19 SAFE Enrollment". In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. The investigators will evaluate th...
What is the current status of trial NCT04506268?
This trial is currently completed. It is a NA study. The enrollment target is 412 participants. The study started on 2020-09-09. Estimated completion is 2020-10-30.
What conditions does trial NCT04506268 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04506268?
The interventions under investigation include: Opt-out Recruitment Email (BEHAVIORAL), Opt-in Recruitment Email (BEHAVIORAL).
Who is sponsoring clinical trial NCT04506268?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04506268 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
RECRUITING · NA
-
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
ACTIVE NOT RECRUITING · NA
-
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
ACTIVE NOT RECRUITING · NA
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Implementation of COVID-19 Testing Strategies in Community Health Centers
COMPLETED · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.